Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group - Hofheinz, Ralf-Dieter; Hegewisch-Becker, Susanne; Kunzmann, Volker; Thuss-Patience, Peter; Fuchs, Martin; Homann, Nils; Graeven, Ullrich; Schulte, Nadine; Merx, Kirsten; Pohl, Michael; Held, Swantje; Keller, Ralph; et al. (International journal of cancer, 2021)
Gesehen am 26.10.2023